Seventeen
Timor treatment via the intracancer injection of a biocompatible gel with radioactive particles
Seventeen has raised €4.2M across 1 funding round from 2 investors, most recently a Series A round in Sep 2016. Based in Italy; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€4.2M
€4,200,000
Funding rounds
1
Investors
2
distinct backers
Active since
2016-09
latest 2016-09
Funding by year
EUR raised per yearSeventeen — funding by year — interactive chart.
Data table
| Seventeen — funding by year | |
|---|---|
| 2016 | €4.2M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-09-01 | Series A | €4.2M | Innogest Capital,Panakès Partners | View deal → |
Investors
2Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Bending Spoons€1.7BItaly · Software
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData